U.S. Tobacco Stock News

NYSE:STWD
NYSE:STWDMortgage REITs

Should Starwood Property Trust’s $400 Million Cash Buyback Shift How STWD Investors View Its Risk Profile?

In late February 2026, Starwood Property Trust, Inc. announced that its board had authorized a one-year share repurchase program of up to US$400 million, to be funded entirely from existing cash. This buyback authorization, following the company’s full-year 2025 results, signals a clear willingness to return capital while balancing earnings, leverage, and portfolio risk considerations. We’ll now examine how this sizable cash-funded buyback authorization may influence Starwood Property...
NYSE:XYL
NYSE:XYLMachinery

The Bull Case For Xylem (XYL) Could Change Following A New US$1.5 Billion Buyback Authorization

In February 2026, Xylem Inc. announced that its Board of Directors had approved a new share repurchase program, authorizing the company to buy back up to US$1.50 billion of its own stock with no expiration date. This move follows the completion of a prior authorization under which Xylem repurchased 5,200,000 shares for US$321.90 million, highlighting an ongoing preference for returning capital to shareholders alongside reinvestment in the business. We’ll now explore how this sizable,...
NasdaqGS:SSNC
NasdaqGS:SSNCProfessional Services

How Earnings Beat And AI CRM Launch At SS&C Technologies (SSNC) Have Changed Its Investment Story

In late February 2026, SS&C Technologies Holdings, Inc. reported an 8.1% year-on-year revenue increase that exceeded analyst expectations and raised its full-year EPS and revenue guidance, citing strong execution and the breadth of its software and services portfolio. A few days earlier, SS&C announced a generative AI-powered sales enablement solution developed with Thornburg Investment Management, embedding advisor insights directly into CRM systems to streamline how asset managers prepare...
NYSE:BRX
NYSE:BRXRetail REITs

A Look At Brixmor Property Group (BRX) Valuation After Recent Share Price Momentum

Why Brixmor Property Group Stock Is On Investors’ Radar Brixmor Property Group (BRX) has drawn fresh attention after recent trading left the stock with a month return of 6.2% and a past 3 months move of 21.9%, prompting closer scrutiny of the REIT’s fundamentals. See our latest analysis for Brixmor Property Group. At a share price of US$30.07, Brixmor’s recent 6.2% 1 month and 21.9% 3 month share price returns contrast with some softer short term moves. Its 1 year and multi year total...
NYSE:DTM
NYSE:DTMOil and Gas

Evaluating DT Midstream (DTM) After EBITDA Growth, Pipeline Expansion, Project Backlog Jump And Dividend Increase

DT Midstream (DTM) has drawn fresh attention after reporting 17% year-over-year adjusted EBITDA growth for 2025, expanding its Pipeline segment to 70% of the business and raising its quarterly dividend by 7.3%. See our latest analysis for DT Midstream. The latest operational update seems to line up with recent market interest, with a 30 day share price return of 10.1% and a 90 day share price return of 17.5%. The 1 year total shareholder return of 65.6% and 3 year total shareholder return of...
NasdaqGM:BCAX
NasdaqGM:BCAXBiotechs

A Look At Bicara Therapeutics (BCAX) Valuation After FICERA Data And Capital Raise

Bicara Therapeutics (BCAX) is back on investor watch after reporting a 54% overall response rate for its FICERA program, alongside a recent public equity raise that supports continued clinical development and early commercial planning. See our latest analysis for Bicara Therapeutics. The recent FICERA update and capital raise come after a 20.25% 1 month share price return and a 12.76% year to date share price return. The 1 year total shareholder return of 11.60% suggests momentum is starting...
NYSE:TR
NYSE:TRFood

How Investors May Respond To Tootsie Roll Industries (TR) Earnings Growth Outpacing Sales And Stock Dividend

In late February 2026, Tootsie Roll Industries reported past full-year 2025 results showing revenue of US$732.52 million and net income of US$100.05 million, alongside a previously announced 1.03% stock dividend effective March 5, 2026. An interesting takeaway is that earnings per share from continuing operations rose to US$1.3301, outpacing the company’s revenue increase over the same period. We’ll now look at how this earnings expansion, alongside the modest stock dividend, shapes Tootsie...
NYSE:SES
NYSE:SESElectrical

SES AI (SES) Is Down 31.1% After Guiding Lower For 2026 And Pivoting From EV Batteries – Has The Bull Case Changed?

In early March 2026, SES AI Corporation reported full-year 2025 results showing sales of US$21.00 million, a smaller net loss of US$73.04 million, a Q4 revenue shortfall versus expectations, and new 2026 revenue guidance of US$30.00 million to US$35.00 million alongside a projected reset in gross margins. The earnings release also revealed a pivot away from automotive battery mass production toward energy storage systems, drones, and materials, while logistics-driven shipment delays and...
NYSE:VMC
NYSE:VMCBasic Materials

Vulcan Materials Faces Earnings Miss As Demand Concerns Lift Bearish Bets

Vulcan Materials (NYSE:VMC) reported quarterly results that came in below expectations, alongside softer guidance for the near term. J.P. Morgan downgraded the stock and flagged the possibility that demand growth could stay subdued until 2027. Short interest in Vulcan Materials has risen, pointing to increased bearish positioning in the shares. Vulcan Materials, trading at $274.99, is coming off a tough stretch, with the stock down 11.3% over the past week and 15.1% over the past month...
NasdaqGS:CBSH
NasdaqGS:CBSHBanks

Did Analyst Upgrade and Portfolio Shifts Just Recast Commerce Bancshares' (CBSH) Role in Regional Banking?

In recent days, Commerce Bancshares (NASDAQ: CBSH) has come into focus after an analyst rating upgrade and shifts in institutional portfolios around the regional bank. This attention, framed by comparisons to trends linked to the Nasdaq 100 index, has intensified discussion of how Commerce Bancshares fits into broader banking exposure. We will now examine how the recent analyst upgrade, alongside institutional portfolio changes, could shape Commerce Bancshares’ evolving investment...
NasdaqCM:ALTO
NasdaqCM:ALTOChemicals

Alto Ingredients (ALTO) Is Up 92.5% After Returning To Profit On Clean Fuel Tax Credit Benefits

In early March 2026, Alto Ingredients reported fourth-quarter 2025 sales of US$231.97 million and net income of US$21.81 million, marking a shift from a loss a year earlier and delivering positive earnings per share for both the quarter and full year. This earnings release highlighted how portfolio realignment, improved crush margins, higher-value renewable fuel exports, and benefits from the 45Z clean fuel production credit collectively turned prior losses into profit across Alto’s...
NasdaqGS:USLM
NasdaqGS:USLMBasic Materials

United States Lime & Minerals (USLM) Valuation After ISM Manufacturing Report And Margin Expansion Expectations

United States Lime & Minerals (USLM) jumped 9.9% after the February ISM Manufacturing report highlighted rising input prices, which investors interpreted as potential pricing power and margin support for industrial suppliers. See our latest analysis for United States Lime & Minerals. That ISM driven jump comes on top of a 1 year total shareholder return of 30.39% and a very large 3 year total shareholder return of 294.55%, even though the year to date share price return is slightly negative...
NasdaqCM:FRHC
NasdaqCM:FRHCCapital Markets

Freedom Holding (FRHC) Is Up 9.4% After S&P Affirms B- Rating Amid Ecosystem Expansion

S&P Global Ratings recently confirmed Freedom Holding Corp.’s long-term issuer credit rating at “B-” with a Stable outlook, while assigning Positive outlooks to key operating subsidiaries as the group expands its brokerage, banking, and broader financial ecosystem. The inclusion of newer areas such as telecommunications and artificial intelligence within Freedom Holding’s growing ecosystem highlights how the group is broadening its business mix beyond traditional financial services. We’ll...
NYSE:PLOW
NYSE:PLOWMachinery

Does Douglas Dynamics (PLOW) Pair Its 2026 Sales Outlook With a Durable Capital Return Strategy?

Douglas Dynamics, Inc. has already reported fourth-quarter 2025 results, with sales rising to US$184.54 million and net income reaching US$12.84 million, alongside full-year 2025 sales of US$656.05 million and a quarterly dividend of US$0.295 per share declared for payment on March 31, 2026. Management’s 2026 net sales outlook of US$710 million to US$760 million, combined with higher quarterly earnings versus the prior year, has prompted analysts to reassess how earnings quality, demand...
NYSE:SCL
NYSE:SCLChemicals

A Look At Stepan (SCL) Valuation After Earnings, Goodwill Impairment And Dividend Reaffirmation

Why Stepan’s latest earnings matter for shareholders Stepan (SCL) just released fourth quarter and full year 2025 results, pairing higher quarterly sales and net income with a goodwill impairment charge and a reaffirmed quarterly cash dividend of $0.395 per share. This mix of earnings, impairment and dividend news gives you a fresh look at how the chemical producer is balancing reported profitability, balance sheet adjustments and ongoing cash returns to shareholders. See our latest analysis...
NYSE:AZO
NYSE:AZOSpecialty Retail

How Investors May Respond To AutoZone (AZO) Rising Sales, Softer EPS And Ongoing Massive Buybacks

AutoZone, Inc. reported past second-quarter 2026 results showing sales rising to US$4,274.10 million from US$3,952.01 million a year earlier, while net income eased to US$468.86 million and diluted EPS from continuing operations slipped to US$27.63. Alongside these mixed results, AutoZone continued its long-running capital return program, repurchasing 85,000 shares for US$310.80 million and bringing total buybacks since 2008 to about US$32.36 billion. Next, we'll examine how rising sales but...
NYSE:AMH
NYSE:AMHResidential REITs

The Bull Case For American Homes 4 Rent (AMH) Could Change Following Share Buyback And Softer Rental Demand

In late February and early March 2026, analysts including Citi, Raymond James, and Barclays turned more cautious on American Homes 4 Rent, citing softer rental demand, elevated new supply, and rising concessions across single-family and multifamily markets. At Citi’s Miami Global Property CEO Conference 2026, American Homes 4 Rent outlined its response with a new US$500 million share repurchase authorization and plans to develop about 1,900 homes in 2026 while closely tracking legislative...
NYSE:GHC
NYSE:GHCConsumer Services

How Graham Holdings’ Earnings Slide and Steady Dividend Will Impact Graham Holdings (GHC) Investors

Graham Holdings Company recently reported its fourth-quarter and full-year 2025 results, with quarterly sales edging up to US$1,251.02 million while net income and earnings per share from continuing operations fell sharply year over year, alongside US$10.10 million of impairment charges on intangible and other long-lived assets. The company’s decision to maintain a regular quarterly dividend of US$1.88 per share, even as full-year net income dropped significantly, highlights a continued...
NasdaqGS:SWBI
NasdaqGS:SWBILeisure

A Look At Smith & Wesson (SWBI) Valuation After Quarterly Earnings And Dividend Announcement

Quarterly earnings and dividend catch investors’ attention Smith & Wesson Brands (SWBI) recently reported third quarter results alongside a fresh dividend announcement. This gives investors new data on both operating performance and direct cash returns. For the quarter ended January 31, 2026, sales were US$135.71 million compared with US$115.89 million a year earlier, while net income was US$3.75 million versus US$2.10 million. See our latest analysis for Smith & Wesson Brands. The earnings...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

Does Nurix Therapeutics' (NRIX) Expanded ATM Capacity Reframe Its Balance Between Funding Flexibility and Dilution?

Nurix Therapeutics recently amended its equity distribution agreement to allow sales of up to US$413.65 million of common stock through Piper Sandler under its existing shelf registration. This expanded at-the-market facility gives Nurix added funding flexibility, potentially affecting how investors assess its balance between capital needs and ownership dilution. We will now examine how this enlarged at-the-market capacity shapes Nurix’s investment narrative, particularly around funding...
NYSE:AESI
NYSE:AESIEnergy Services

Can Atlas Energy Solutions (AESI) Turn Dune Express Momentum And Power Diversification Into Sustainable Profits?

In February 2026, Atlas Energy Solutions reported fourth-quarter 2025 revenue of US$249.43 million and a quarterly net loss of US$22.24 million, while full-year 2025 revenue rose to US$1.10 billion alongside a full-year net loss of US$50.30 million versus a profit the year before. Despite swinging to losses, Atlas highlighted record utilization of its Dune Express system and new initiatives in power generation aimed at broadening its revenue base beyond traditional sand and logistics. We’ll...
NasdaqGS:DSGR
NasdaqGS:DSGRTrade Distributors

Assessing Distribution Solutions Group (DSGR) Valuation After Earnings Miss And Rising Legal Scrutiny

What triggered the latest move in Distribution Solutions Group? Distribution Solutions Group (DSGR) is back in focus after its fourth quarter and full year 2025 earnings missed analyst expectations on both revenue and earnings, pressuring margins and sparking legal scrutiny following a sharp share price reaction. See our latest analysis for Distribution Solutions Group. The sharp post earnings drop has fed into a wider reset in expectations, with a 7 day share price return of 26.12% and a...
NasdaqGS:IMVT
NasdaqGS:IMVTBiotechs

Immunovant (IMVT) Valuation After IMVT-1402 Trial Enrollment Milestone And US$550 Million Capital Raise

Why Immunovant is back on investors’ radar Immunovant (IMVT) has drawn fresh attention after completing enrollment in a potentially registrational IMVT-1402 trial for difficult rheumatoid arthritis, alongside a roughly US$550 million capital raise from institutional investors. See our latest analysis for Immunovant. At a share price of US$26.66, Immunovant has recently seen a 15.06% 90 day share price return and a 33.17% 1 year total shareholder return. This suggests momentum has built over...
NYSE:PNR
NYSE:PNRMachinery

Assessing Pentair (PNR) Valuation After Recent Short-Term Share Price Weakness

Pentair stock snapshot and recent performance Pentair (PNR) has been on many watchlists after a period of weaker share performance, with the stock showing negative returns over the past week, month, and past 3 months despite a positive 1 year total return. See our latest analysis for Pentair. At a share price of $92.17, Pentair’s recent 1 day, 7 day and 90 day share price returns have been negative, while its 1 year and 3 year total shareholder returns remain positive, suggesting shorter term...